Patents Examined by Michael Meller
  • Cleanser compositions and methods for using the same
    Patent number: 9050288
    Abstract: The present invention is directed to anti-microbial cleanser compositions comprising linalool, hinokitiol and dipropylene glycol. The present invention further provides methods for using these compositions to maintain eyelid hygiene, to treat an ocular disorder or to clean a skin surface. The cleanser compositions of the present invention can be in the form of a foam, gel or liquid.
    Type: Grant
    Filed: October 30, 2014
    Date of Patent: June 9, 2015
    Assignee: ADVANCED VISION RESEARCH, INC.
    Inventors: Jeffrey Gilbard, Yanick Douyon, Robert B Huson
  • Medicinal compositions containing honey
    Patent number: 9044489
    Abstract: The present invention relates to medicinal compositions containing a honey having non peroxide antibacterial activity and wherein the composition comprises from about 19% to about 80% water by weight. The use of these compositions in the treatment of eye, respiratory and ear conditions is also disclosed.
    Type: Grant
    Filed: October 28, 2013
    Date of Patent: June 2, 2015
    Assignee: Medihoney Pty Ltd.
    Inventor: Anthony Peter Moloney
  • Nano gold and process for preparation
    Patent number: 9045808
    Abstract: This invention relates to bio synthesis of novel nano gold through environment friendly process with the aid of plant materials classified under the taxonomical genus Dalbergia, Citrus, Ferula and Dolichos or Macrotyloma. The present inventive product novel nano gold finds utility in, the treatment of humans and animals, nutraceutical, cosmeceutical and herbal composition, the field of technology including but not limited to nano technology, green technology and bio technology. The invention also relates to the use of plant materials in the purification and particle size reduction of metals.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: June 2, 2015
    Inventors: Yogesh N. Bendale, Vineeta Yogesh Bendale
  • Pharmaceutical composition and method of manufacturing
    Patent number: 9044390
    Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: June 2, 2015
    Inventor: Gary J. Speier
  • Methods for inhibiting prostate cancer by kinases and angiogenesis inhibitory mechanisms of ball moss extract
    Patent number: 9040100
    Abstract: A method of treating prostate cancer by administering a pharmaceutically-acceptable amount of a crude extract of the indigenous Jamaican plant Ball Moss (Tillandsia Recurvata) comprising one or more cycloartane isolates, and the isolates used in the method for eliciting thereby a kinase inhibitory response of prostate cancer cells by selectively inhibiting MRCK? kinase and angiogenesis of (growth of new blood vessels) to reduce the viability of prostate cancer cells. The method and compounds holds promise as a chemopreventive agent, without causing excessive damage to normal cells.
    Type: Grant
    Filed: May 6, 2014
    Date of Patent: May 26, 2015
    Inventors: Henry Lowe, Joseph L. Bryant
  • Method to treat diabetes utilizing a gastrointestinal microbiome modulating composition
    Patent number: 9040101
    Abstract: Compositions and methods for treating diabetes are presented herein. In particular, the present disclosure teaches compositions and methods for treating diabetes utilizing a gastrointestinal microbiome modulating composition.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: May 26, 2015
    Assignee: MicroBiome Therapeutics LLC.
    Inventors: Mark L. Heiman, Dean P. Stull, Justin W Peno
  • Medical delivery devices and methods for applying a barrier composition to a targeted skin surface
    Patent number: 9028884
    Abstract: Some embodiments of a system or method for applying a barrier composition to a targeted skin surface can be used to as a preventative measure to reduce the likelihood of transmission of microbial entities from an external source (e.g., a floor surface or another surface) to the targeted skin surface.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: May 12, 2015
    Assignee: Preventamedics LLC
    Inventors: Aner Vlodaver, Benhoor Soumekh, Smarajit Mitra, Sumita B. Mitra
  • Pharmaceutical composition using stryphnodendron extracts for treating HPV infections
    Patent number: 9023405
    Abstract: The application of extracts, mainly the alcoholic, hydroalcoholic, and aqueous extracts of the bark, bark seam, stem, and seedpod skin of Abarema cochliocarpos (Gomes) Barneby & Grimes and/or Stryphnodendron barbatiman, Stryphnodendron coriaceum Benth., S. diacolor Benth., S. pulcherrimum (Wildd) Hoch., Stryphnodendron adstringens (Mart.) Coville, Stryphnodendron obovatum Benth., Stryphnodendron polyphyllum M., and Pithecellobium avaremotemo Mart., all popularly known as barbatimão, as adjuvants in pharmaceutical compositions for treatment of infections related to the human papillomavirus (HPV) and cervical cancer prophylaxis.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: May 5, 2015
    Assignee: Universidade Federal de Alagoas—UFAL
    Inventors: Manoel Alvaro de Freitas Lins Neto, Luiz Carlos Caetano, Pedro Accioly de Sa Peixoto Neto, Zenaldo Porfirio Da Silva
  • Radiopaque bone repair mixture and method of use
    Patent number: 9017740
    Abstract: A composition of a bone repair mixture has a quantity of allograft particulate bone having a bone particle distribution of particle sizes less than 700 micron and a quantity of biologic carrier material intermixed with the particulate bone. The biologic carrier material is one of fascia, deep fascia or a fascia mixture. Preferably, the carrier material is exclusively fascia lata.
    Type: Grant
    Filed: January 6, 2015
    Date of Patent: April 28, 2015
    Assignee: Vivex Biomedical, Inc.
    Inventors: Tracy Scott Anderson, Timothy E Taylor
  • Method for suppressing and relieving itching and inflammation
    Patent number: 9017739
    Abstract: The present invention provides a method for suppressing and relieving itching and inflammation, by administering to a host in need of such treatment an effective amount of the pharmaceutical composition containing highly lipophilic polyalkoxyflavonoid. The pharmaceutical composition and functional food of the present invention for suppressing and relieving itching and inflammation contain highly lipophilic polyalkoxyflavonoid extracted from squeezed juice of a whole portion of a citrus fruit (inclusive of pericarp thereof). Furthermore, the functional food of the present invention contains it.
    Type: Grant
    Filed: October 18, 2014
    Date of Patent: April 28, 2015
    Assignees: Kands R&D Corporation, Erina Co., Inc.
    Inventors: Kazue Taguchi, Shigeru Taguchi, Yutaka Sashida
  • Methods and formulations for treating chronic liver disease
    Patent number: 9011938
    Abstract: An anti-inflammatory and anti-fibrotic antioxidant formulation for treatment of hepatic oxidative stress and cirrhosis is disclosed. The antioxidant formulation can further include at least one of a hepatitis C virus-specific or a non-alcoholic steatohepatitis-specific formulation comprising one or more compounds to retard the progression of liver fibrosis and possibly reverse an established fibrosis. Methods of treatment or therapies for treating chronic liver disease and chronic hepatitis are also provided.
    Type: Grant
    Filed: May 8, 2012
    Date of Patent: April 21, 2015
    Inventor: George Zabrecky
  • Bitter-taste inhibitor and ginseng composition comprising same
    Patent number: 9011940
    Abstract: The present invention relates to a bitter-taste inhibitor containing indigestible maltodextrin, and to a ginseng composition comprising the bitter-taste inhibitor. According to the present invention, the particular bitter taste of ginseng may be eliminated without the loss of a marker component found in ginseng, thereby enabling the easy intake of ginseng.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: April 21, 2015
    Assignee: Amorepacific Corporation
    Inventors: Su Hwan Kim, Chan Woong Park, Jin Yeong Shin, Wan Gi Kim, Sang Jun Lee
  • Solvent-free process for obtaining phospholipids and neutral enriched krill oils
    Patent number: 9011942
    Abstract: The invention discloses a new solvent-free process for obtaining phospholipids and neutral lipids enriched krill oils containing DHA and EPA poly-unsaturated fatty acids and astaxanthin. The process includes cooking fresh krill at high temperature—without agitation and or grinding; decanting the cooked krill for obtaining a partial de-fatted and de-watered solid and a liquid; squeezing the obtained solid to obtain a press liquid and a solid fraction; centrifuging the press liquid to obtain the phospholipids enriched krill oil; centrifuging of the decanter liquid obtained to obtain the neutral lipid enriched krill oil and stickwater.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: April 21, 2015
    Assignee: Tharos, Ltd.
    Inventors: Dimitri Sclabos Katevas, Raúl R. Toro Guerra, Mario Chiong Lay
  • Sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans for treating diseases caused by the influenza virus
    Patent number: 9011939
    Abstract: The present invention relates to polysaccharides selected from sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans intended to be used as a drug for the preventive or curative treatment of an influenza virus, as well as to the pharmaceutical compositions including, in particular in combination with at least one pharmaceutically acceptable carrier: either an extract of Codium fragile, including sulphated arabinogalactans, or an extract of Zostera marina or Lemna minor, including apiogalacturonans, or an extract of Caulerpa racemosa, including sulphated heteroglycans.
    Type: Grant
    Filed: January 3, 2012
    Date of Patent: April 21, 2015
    Assignees: Elicityl, Centre National de la Recherche Scientifique, Insititut National de la Sante et de la Recherche Medicale—I.N.S.E.R.M., Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)
    Inventors: Bruno Lina, Olivier Ferraris, Ho Hong Hai Vo, François-Loïc Cosset, Judit Szecsi, Alain Heyraud, Hugues Lortat-Jacob, Julia Bartoli, Rabia Sadir, Thierry Livache, Benoît Darblade, Stéphane Havet, Silvère Bonnet
  • Combined allergy treatment and anti-drying compositions and related methods
    Patent number: 9011941
    Abstract: Compositions and methods for alleviating an allergy condition while also reducing a drying effect of an allergy treatment composition or another anti-mucosal composition. In some embodiments and implementations, a composition may be provided comprising an allergy treatment composition comprising an antihistamine in a therapeutically effective amount for treating the allergy condition in the human having the allergy condition. The composition may further comprise an anti-drying composition comprising at least one of xylitol, erythiritol, mannitol, maltitol, tibitol, arabitol, ribose, and xylose in one or more therapeutically effective amounts for reducing nasal dryness caused by the allergy treatment composition. The composition may be delivered into at least one of the human's nose, eyes, mouth, and throat.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: April 21, 2015
    Assignee: Xlear, Inc.
    Inventors: Alonzo H. Jones, Nathan Jones
  • Pharmaceutical composition for treating cancer and use thereof
    Patent number: 9005678
    Abstract: The present invention discloses a pharmaceutical composition for treating cancer, comprising: (1) a herbal composition generated from Astragali membranaceus radix, Cinnamomi cortex, Paeonia alba radix, Jujubae fructus, and Zingiberis rhizoma or an extract of the above mixed herbal medicine; (2) one or more chemotherapeutic compounds. The present invention also discloses use of the above pharmaceutical composition in the preparation of medicament for treating human cancer and in the preparation of medicament for reducing side effects of chemotherapeutic compounds in human body. The pharmaceutical composition of the present invention can reduce chemotherapy-induced peripheral neuropathic side effects such as limb paresthesia, pain, cold skin, formication, powerlessness and the like, increase tolerance dosages of anticancer drugs, and enhance efficacy of anticancer drugs.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: April 14, 2015
    Assignee: Jiangsu Province Institute of Traditional Chinese Medicine
    Inventors: Peng Cao, Xiaolan Cheng, Jiege Huo, Xiaoning Wang, Jingqing Hu, Xueting Cai, Yang Yang, Chunping Hu, Guoli Wei
  • Oral compositions comprising propolis
    Patent number: 9005680
    Abstract: Oral compositions are provided that comprise a propolis extract; a halogenated diphenyl ether non-ionic antibacterial agent; an anionic polymeric copolymer of methyl vinyl ether and maleic anhydride; and a source of fluoride ions. The oral composition can be in a form of a mouth rinse, a dentifrice, a confectionary, a medicament, or a film. Methods of making and using the oral compositions are also provided.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: April 14, 2015
    Assignee: Colgate-Palmolive Company
    Inventors: Nataly Fetissova, Claude Blanvalet, Pierre Lambert
  • Pharmaceutical composition and methods for modulating immune system, preventing, pretreating and/or treating cancers
    Patent number: 9005676
    Abstract: This invention provides a pharmaceutical composition for modulating immune system comprising at least one polysaccharide extracted from Radix Astragali, Radix Codonopsis, Ganoderma sinense, or mixtures thereof, and their extraction process. The present invention further relates to a method of modulating immune system by applying said pharmaceutical composition to a subject suffering from cancers, and a method of preventing and/or pretreating and/or treating cancers in the subject, where said method comprises applying said pharmaceutical composition before/during chemotherapy.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: April 14, 2015
    Assignee: Hong Kong Baptist University
    Inventor: Quanbin Han
  • Autophagy enhancer for treatment of neurodegenerative diseases
    Patent number: 9005677
    Abstract: Use and application of Onjisaponin B derived and isolated from Radix Polygalae as novel autophagy enhancer are provided. A method of preventing, treating and/or delaying the onset of neurodegenerative diseases comprising administering an effective amount of Onjisaponin B is also provided.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: April 14, 2015
    Assignee: Macau University of Science and Technology
    Inventors: Yuen Kwan Law, An Guo Wu, Kam Wai Wong, Liang Liu
  • Skin formulation, preparation and uses thereof
    Patent number: 9005675
    Abstract: Serum compositions for application to skin are described which contain an amniotic fluid extract in combination with embryonic stem cells. Formulations containing the serum composition are also described. The serum compositions and formulations may be applied to skin for treatment of symptoms of aging, wounds, burns, scars or other skin lesions. Methods of preparing the serum compositions and formulations are also disclosed.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: April 14, 2015
    Assignee: Golden Pearl Investment LLC
    Inventor: Jin Qian